Sign inJoin waitlistJoin the waitlist

Magdalena E Sobieszczyk

Associate Fellowship Program Director · Columbia University College of Physicians and Surgeons

Credentials: · · · ·

History

Associate Fellowship Program Director Fellowship · Columbia University College of Physicians and Surgeons
Present
Division of Infectious Diseases · Columbia University College of Physicians and Surgeons
Present
Columbia University Medical Center
Present

NewYork-Presbyterian Hospital/Columbia University Medical Center
NewYork-Presbyterian Hospital/Columbia University Medical Center
Columbia University College of Physicians and Surgeons
1998

Research

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Nature · 2021 · 1,817 citations
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
New England Journal of Medicine · 2020 · 1,141 citations
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Nature · 2022 · 1,088 citations

Jason Zucker
59 papers
Lawrence Corey
31 papers
CC
Caroline Carnevale
28 papers
Deborah Theodore
23 papers
Juliana McElrath
22 papers
Lindsey Baden
22 papers
SH
Scott Hammer
21 papers
Alwyn Cohall
17 papers
Ann Falsey
17 papers
Jim Kublin
17 papers
Michael Yin
17 papers
Paul Goepfert
17 papers

Grants

Vagelos College of Physicians & Surgeons Next Generation Physician-Scientist Training Pathway (VP&S-Next Gen PSTP) Program in Infectious Diseases and Immunology
National Institute of Allergy and Infectious Diseases · R38
PI · $619.5K · Columbia University Health Sciences
2026–2031
Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)
National Institute of Allergy and Infectious Diseases · P30
Contact PI · $2.5M · Columbia University Health Sciences
2026–2031
Columbia Integrated Training Program in Infectious Diseases Research
National Institute of Allergy and Infectious Diseases · T32
PI · $1.1M · Columbia University Health Sciences
2013–2028
Columbia Collaborative HIV/AIDS Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $30.2M · Columbia University Health Sciences
2007–2027

Clinical trials

Stick2PrEP Cisgender Women and Trans Individuals
Principal investigator · Recruiting
Columbia University
2021–2026
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
Principal investigator · Active not recruiting
Columbia University
2021–2027
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Principal investigator · Recruiting
Columbia University
2020–2027
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2019–2021